Green Ridge Wealth Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$519K Buy
1,983
+85
+4% +$21.8K 0.21% 48
2026
Q2
$478K Sell
1,898
-2
-0.1% -$430 0.2% 49
2026
Q1
$413K Buy
1,900
+2
+0.1% +$444 0.22% 52
2025
Q4
$434K Buy
+1,898
New +$432K 0.22% 51

Other funds holding ABBV

Green Ridge Wealth Planning's ABBV Position: Q3 2026 in Review

Green Ridge Wealth Planning increased its AbbVie (ABBV) stake by 4.5% in Q3 2026, buying an estimated $21.8K and bringing the position to 1,983 shares worth $519K. The position accounts for 0.21% of the portfolio, ranked #48.

Green Ridge Wealth Planning first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 165 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Green Ridge Wealth Planning held 1,983 shares of AbbVie worth $519K as of Q3 2026.
  • Green Ridge Wealth Planning bought 85 AbbVie shares in Q3 2026, an estimated $21.8K.
  • AbbVie made up 0.21% of Green Ridge Wealth Planning's portfolio in Q3 2026, its #48 holding.
  • Green Ridge Wealth Planning first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 165 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Green Ridge Wealth Planning's 13F filing for Q3 2026, filed 8 Oct 2026.